Inspira Technologies Oxy BHN (IINN) has released an update.
Inspira Technologies Oxy BHN Ltd., a pioneering medical technology firm, has announced the Israeli Ministry of Health’s approval for its innovative INSPIRA ART100 system, following FDA clearance. This approval is seen as a critical step in the company’s global business development plans, which include expanding into new markets beyond the U.S. The ART100 system offers advanced life support technology, aiming to improve patient treatment by allowing for oxygenation without the need for intubation.
For further insights into IINN stock, check out TipRanks’ Stock Analysis page.
